{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T04:42:13Z","timestamp":1781239333543,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.tjog.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T07:08:50Z","timestamp":1656572930000},"page":"573-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chemotherapy adjuvant and chemotherapy-induced neutropenia"],"prefix":"10.1016","volume":"61","author":[{"given":"Yiu-Tai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjog.2022.05.001_bib1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.tjog.2021.09.027","article-title":"Endometriosis-associated epithelial ovarian cancer is a more complicated disease than we suspected before","volume":"60","author":"Yang","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/JCMA.0000000000000643","article-title":"Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma","volume":"85","author":"Su","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.tjog.2022.05.001_bib3","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/JCMA.0000000000000629","article-title":"Synergistic therapeutic effect of low-dose bevacizumab with cisplatin-based chemotherapy for advanced or recurrent cervical cancer","volume":"84","author":"Liu","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.tjog.2022.05.001_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tjog.2021.11.002","article-title":"Fertility preservation in women with breast cancer","volume":"61","author":"Chen","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.tjog.2021.09.004","article-title":"Fever during chemotherapy: hypersensitivity reactions","volume":"60","author":"Lee","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.tjog.2020.05.034","article-title":"Gastrointestinal perforations in a patient treated by Bevacizumab and chemotherapy: is it an anaphylactic reaction?","volume":"59","author":"Lee","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/JCMA.0000000000000242","article-title":"Uterine sarcoma: an unusual but high lethal disease of gynecological malignancies","volume":"83","author":"Lee","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.tjog.2022.05.001_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12885-021-08258-w","article-title":"Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety","volume":"21","author":"Mahtani","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tjog.2022.05.001_bib9","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.3390\/ijerph16234794","article-title":"Weekly dose-dense paclitaxel and triweekly low-dose cisplatin: a well-tolerated and effective chemotherapeutic regimen for first-line treatment of advanced ovarian, Fallopian tube, and primary peritoneal cancer","volume":"16","author":"Cheng","year":"2019","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.tjog.2022.05.001_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tjog.2020.03.001","article-title":"Dose-dense chemotherapy: a possible high cost-effectiveness treatment for ovarian cancer","volume":"59","author":"Huang","year":"2020","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib11","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.3390\/ijerph17072213","article-title":"Comparing paclitaxel-carboplatin with paclitaxel-cisplatin as the front-line chemotherapy for patients with FIGO IIIC serous-type tubo-ovarian cancer","volume":"17","author":"Huang","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.tjog.2022.05.001_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/JCMA.0000000000000283","article-title":"Immunology and ovarian cancers","volume":"83","author":"Lee","year":"2020","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.tjog.2022.05.001_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tjog.2022.02.013","article-title":"Effect of primary prophylaxis with pegfilgrastim in endometrial cancer patients treated with doxorubicin and cisplatin","volume":"61","author":"Tojima","year":"2022","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1016\/j.tjog.2022.05.001_bib14","doi-asserted-by":"crossref","first-page":"e3330","DOI":"10.1097\/MD.0000000000003330","article-title":"Outcomes of patients with surgically and pathologically staged IIIA-IVB pure endometrioid-type endometrial cancer: a Taiwanese Gynecology Oncology Group (TGOG-2005) retrospective cohort study (A STROBE-Compliant Article)","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.tjog.2022.05.001_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/JCMA.0000000000000729","article-title":"Abandon ifosfamide-based regimen and use paclitaxel-carboplatin regimen for the treatment of uterine carcinosarcoma","volume":"85","author":"Yang","year":"2022","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.tjog.2022.05.001_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1200\/JCO.21.02667","article-title":"Paclitaxel and carboplatin for uterine carcinosarcoma: a path to inclusion","volume":"40","author":"Roque","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tjog.2022.05.001_bib17","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1200\/JCO.21.02050","article-title":"Randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and ifosfamide in patients with carcinosarcoma of the uterus or ovary: an NRG oncology trial","volume":"40","author":"Powell","year":"2022","journal-title":"J Clin Oncol"},{"issue":"5 Suppl","key":"10.1016\/j.tjog.2022.05.001_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.6004\/jnccn.2014.0198","article-title":"Treatment strategies for myeloid growth factors and intravenous iron: when, what, and how?","volume":"12","author":"Crawford","year":"2014","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["Taiwanese Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1028455922001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:20:03Z","timestamp":1760898003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1028455922001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1028455922001346"],"URL":"https:\/\/doi.org\/10.1016\/j.tjog.2022.05.001","relation":{},"ISSN":["1028-4559"],"issn-type":[{"value":"1028-4559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy adjuvant and chemotherapy-induced neutropenia","name":"articletitle","label":"Article Title"},{"value":"Taiwanese Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjog.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}